![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug Research
Centivax partners with US NMRC to study Covid-19 antibody
Centivax has signed a strategic collaboration with the US Naval Medical Research Center (NMRC) to conduct Phase I clinical development of its SARS-CoV-2 antibody,...
Drug Research
Pacira BioSciences, Inc. partners with Ashfield Engage to deliver European commercial infrastructure
Ashfield Engage, part of UDG Healthcare plc, announced that it has been selected by US-based Pacira BioSciences, Inc. to provide strategic commercialization services for...
Drug Research
Engine Biosciences expands its digital drug discovery pipeline with $43M round
Drug discovery is a large and growing field, encompassing both ambitious startups and billion-dollar Big Pharma incumbents. Engine Biosciences is one of the former,...
Drug Research
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services
Samsung Biologics , a leading global CDMO providing end-to-end contract development and manufacturing services, announced its plans to add mRNA vaccine drug substance (DS)...
Drug Research
Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb
Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company. This expanded...
Drug Research
Agilex Biolabs Toxicology Tapped for SARS-CoV-2 Vaccine Research
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed...
Drug Research
Dr. Reddy’s Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India
Dr. Reddy's Laboratories Ltd. announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company ("Lilly") for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read